Kissei Pharmaceutical Co Ltd

Kissei Pharmaceutical has established limited processes to align its indirect external engagement on climate issues with its climate commitments, primarily through industry association participation, but it does not disclose a formal policy or dedicated oversight for its lobbying activities. The company reports that "å½"社はæ - ¥æœ¬è£½è - ¬å·¥æ¥­å"会（製è - ¬å"）のç'°å¢ƒå•é¡Œæ¤œè¨Žä¼šï¼ˆ2022å¹´4月発足）にメンバーとだ- ã¦å‚åŠ ã - ã¦ãŠã‚Šã€æ° - 候変動問題に対する課題検討やæ - ¥æœ¬è£½è - ¬å›£ä½"連合会（æ - ¥è - ¬é€£ï¼‰ç'°å¢ƒå§"å"¡ä¼šã¸ã®ç'°å¢ƒå•é¡Œã«é - ¢ã™ã‚‹è£½è - ¬å"の意見のとりまとめ等ã‚'行う", and that "検討会でのå†...容についてはå½"社å†...のサステナãƒ"リティ推進å§"å"¡ä¼šï¼ˆæ - §SDGs推進å§"å"¡ä¼šï¼‰ã«ãŠã„てもæƒ...å ±å...±æœ‰ã - 、社å†...での行動推進に繋ã'ていく", demonstrating an internal committee reviewing and promoting actions based on association discussions. The company also notes its continued cooperation on the "æ - ¥è - ¬é€£ã‚«ãƒ¼ãƒœãƒ³ãƒ‹ãƒ¥ãƒ¼ãƒˆãƒ©ãƒ«è¡Œå‹•è¨ˆç"»" through surveys, showing engagement at the indirect lobbying level. However, the company does not disclose any process for direct lobbying alignment, no named individual or formal governance body responsible for approving or reviewing lobbying positions, and states "No, and we do not plan to have one in the next two years" regarding a public commitment to align engagement with the Paris Agreement, indicating an absence of a comprehensive climate-lobbying governance framework.